
A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer
Keywords: سرطان ریوی غیر سلول کوچک; AE; adverse event; CTCAE; common terminology criteria for adverse events; CI; confidence interval; DFS; disease-free survival; IHC; immunohistochemistry; i.v.; intravenous; MedDRA; medical dictionary for regulatory activities; NSCLC; Non-Small-Cell Lung C